跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 83 条关于
“Catenion”
全部
83
临床试验
22
药物
46
机构
4
资讯
11
3个月前
Novo Nordisk Foundation Unveils Strategic Roadmap to Revitalize Regenerative Medicine in Europe
7个月前
Dewpoint Therapeutics Initiates First-in-Human Trial of Novel Beta-Catenin Condensate Modulator DPTX3186
7个月前
New Classification System Predicts Immunotherapy Response in Liver Cancer Patients with β-Catenin Mutations
7个月前
Iterion Therapeutics Initiates First-in-Class Wnt/β-Catenin Inhibitor Trial for Relapsed Osteosarcoma
8个月前
Parabilis Medicines Secures $305 Million Series F to Advance First-in-Class β-Catenin Inhibitor Zolucatetide
2个月前
TCR-Engineered T Cells Targeting Shared β-Catenin Mutation Eradicate Solid Tumors, Earns OUS Research Prize
4个月前
Federal Circuit Affirms Noninfringement Ruling in Actelion-Mylan Hypertension Drug Patent Dispute
10个月前
FDA Grants Fast Track Designation to FOG-001, First-in-Class β-Catenin Inhibitor for Desmoid Tumors
9天前
Parabolus Medicines' zolocatetide posts 74% response rate in desmoid tumors, targeting the undruggable beta-catenin/TCF complex
5个月前
Sapience Therapeutics Reports 47% Response Rate for First-in-Class β-Catenin Antagonist ST316 in Second-Line Colorectal Cancer
第 1 页,共 2 页
上一页
下一页